Hence, our aim has been to provide a proof of concept regarding the possible correlation of serum vitronectin fragments with histopathology in patients affected by NAFLD and its putative role in the assessment of disease severity. The gene discussed is VTN; the disease is metabolic dysfunction-associated steatotic liver disease.